X
17Aug

UK Life Sciences and Healthcare Newsletter - August 2020: COVID-19 – How Have Listed Companies Fared?

Dechert LLP | | Return|
COVID-19 has had a significant financial impact on many listed companies and, in recent months, there has been a marked increase in equity capital raises by listed companies. As at 22 July 2020, there have been over 100 secondary equity fundraisings in excess of £10 million on the Main Market and AIM since the COVID lockdown period began. Some have had to raise emergency capital, on short notice and often at significant discounts, whereas others have sought to shore up their balance sheets as...
By: Dechert LLP
Source Url: https://www.jdsupra.com/legalnews/uk-life-sciences-and-healthcare-82301/

Related

Taxable M&A And The Unwanted Asset

Under One Roof- I sometimes wonder at the number of corporations that own real property. It is oft...

Read More >

The Activism Vulnerability Report - Q3 2019

FTI Consulting (“FTI”) welcomes our clients and friends to our inaugural edition of The Activism V...

Read More >

Weekly IRS Roundup September 23 – 27, 2019

Presented below is our summary of significant Internal Revenue Service (IRS) guidance and relevant t...

Read More >

[Video] Creativity and Compliance- Corporate Compliance and Ethics Week, Part 4-Speakers and Keynotes

Where does creativity fit into compliance? In more places than you think. Problem-solving, accountab...

Read More >

We Need to Preserve and Protect Whistleblowing in This Time of Challenge

Many compliance officers over the years have wished for the day when what we do is at the forefront ...

Read More >

M&A Risk Allocation: Drafting and Litigation Considerations in the Era of COVID-19

Risk allocation between parties is a key consideration in the negotiation of merger and acquisition ...

Read More >